CDT Equity Inc. (NASDAQ:CDT)
| Market Cap | 644.33K-100.0% |
| Revenue (ttm) | 1.45B |
| Net Income | 91.12M+563.8% |
| EPS | 81.03+98.2% |
| Shares Out | 1.12M |
| PE Ratio | 0.01 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 474,043 |
| Open | 0.90 |
| Previous Close | 0.93 |
| Day's Range | 0.82 - 0.90 |
| 52-Week Range | 0.80 - 37500.00 |
| Beta | 1.56 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About CDT
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CDT stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in CDT holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CDT's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CDT Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CDT Revenue by Segment or Geography
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New CDT patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CDT from public contracts
Source: USAspending.gov
CDT Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CDT’s recent data — informational, not investment advice